Advisory Research’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $580K | Buy |
|
|||||
|
2025
Q1 | $564K | Buy |
|
|||||
|
2024
Q4 | $621K | Buy |
|
|||||
|
2024
Q3 | $533K | Buy |
|
|||||
|
2024
Q2 | $448K | Buy |
|
|||||
|
2024
Q1 | $535K | Sell |
|
|||||
|
2023
Q4 | $478K | Sell |
|
|||||
|
2023
Q3 | $484K | Sell |
|
|||||
|
2023
Q2 | $544K | Buy |
|
|||||
|
2023
Q1 | $630K | Buy |
|
|||||
|
2022
Q4 | $612K | Sell |
|
|||||
|
2022
Q3 | $905K | Buy |
|
|||||
|
2022
Q2 | $770K | Buy |
|
|||||
|
2022
Q1 | $783K | Buy |
|